- E11 -

Search All Active Clinical Trials Featured TrialMyeloma Treatment Featured TrialMelanoma Treatment Featured TrialHead and Neck Cancer Treatment Featured TrialBreast Cancer Treatment Featured TrialSarcoma Treatment Clinical and Administrative Resources Web Application Portal Submit an Inquiry Update My Roster Profile Other Research Resources Member Blog Resources for Active Trials Training Video Resource Library on YouTube Mentoring Program Group Meeting Presentations Audit Tools and User Groups Specialty PresentationIntegrating PROs in Trials Specialty PresentationImplementation Science Latest News Attention CRAs Travel funds are available for the Spring 2025 Group Meeting apply now WATCH Dr. Kathy Miller on how the PATINA trial AFT38PrE0111 shifts the paradigm in HER2ER breast cancer treatment Attention APPs Travel funds are available for the Spring 2025 Group Meeting apply now Attention radiation oncologists and trainees Travel funds are available for the Spring 2025 Group Meeting apply now LISTEN A JAMA Network Learning podcast interview with Dr. Anand Jillella author of the newly published results of study EA9131 in JAMA Oncology Top trial results of 2024 A year of significant advancements in cancer treatment by ECOGACRIN and PrECOG The February 2025 news from ECOGACRIN blog is now available A statement from the cooperative groups From the group cochairs of ECOGACRIN A perspective on indirect costs requires subscription Posts ECOGACRIN Cancer Research Group Follow 7793 6281 Biomarkerdriven medical research involving adults who have or are at risk of developing cancer The EA3202 clinical study is comparing three possible treatment approaches for patients with advancedstage HeadAndNeckCancer to see which one helps patients live the longest. Learn more httpsbit.